Joint Formulary & PAD

Nimodipine - Subarachnoid haemorrhage

You are here : Home > Formulary Search > Nimodipine - Subarachnoid haemorrhage

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Nimodipine
Indication :
Subarachnoid haemorrhage
Group Name :
Keywords :
ischaemic neurological defects, aneurysmal subarachnoid haemorrhage
Brand Names Include :
Nimotop
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Nimodipine is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Subarachnoid haemorrhage.

  • No records returned.